119,500€
4,82%
Echtzeit-Aktienkurs Mesa Laboratories
Bid:
Ask:
Echtzeit-Chart der Mesa Laboratories Aktie
Börsenkurse Mesa Laboratories
| Börse Frankfurt | - | - | - | - | 119,500€ | 4,82% |
| Tradegate | - | - | - | - | 119,000€ | 4,39% |
| USA | - | - | - | - | 123,000$ | 1,26% |
| Nasdaq | - | - | - | - | 126,160$ | 2,57% |
| gettex | - | - | - | - | 118,500€ | 2,60% |
| Lang & Schwarz | - | - | - | - | 119,000€ | 1,71% |
Fundamentaldaten der Mesa Laboratories Aktie
Aktuelle Geschäftsentwicklung
Sie benötigen die TraderFox Börsensoftware, um die aktuelle Geschäftsentwicklung einsehen zu können.
Income Statement: 10-Year-Summary
| Datum | Umsatz | EBIT | Gewinn | EPS | Dividende | KGV | KUV |
|---|---|---|---|---|---|---|---|
| 2023 [USD] | 219,08 Mio. | -0,39 Mio. | 0,93 Mio. | 0,17 | 0,54% | 686,78 | 2,93 |
| 2022 [USD] | 184,34 Mio. | 3,57 Mio. | 1,87 Mio. | 0,35 | 0,54% | 340,46 | 3,41 |
| 2021 [USD] | 133,94 Mio. | 2,30 Mio. | 3,27 Mio. | 0,64 | 0,54% | 187,01 | 4,59 |
| 2020 [USD] | 117,69 Mio. | 3,43 Mio. | 1,35 Mio. | 0,31 | 0,54% | 386,73 | 4,45 |
| 2019 [USD] | 103,14 Mio. | 8,62 Mio. | 7,48 Mio. | 1,86 | 0,54% | 64,39 | 4,51 |
| 2018 [USD] | 96,18 Mio. | 0,30 Mio. | -2,96 Mio. | -0,79 | 0,54% | - | 4,72 |
| 2017 [USD] | 93,67 Mio. | 14,30 Mio. | 11,18 Mio. | 2,91 | 0,54% | 41,07 | 4,76 |
| 2016 [USD] | 84,66 Mio. | 15,56 Mio. | 11,17 Mio. | 2,97 | 0,54% | 40,24 | 5,13 |
| 2015 [USD] | 71,33 Mio. | 15,35 Mio. | 9,58 Mio. | 2,63 | 0,52% | 45,44 | 5,97 |
| 2014 [USD] | 52,72 Mio. | 13,10 Mio. | 9,00 Mio. | 2,49 | 0,49% | 47,99 | 7,91 |
| Die Multiples wie die KGVs werden mit der Bilanzwährung und dem Kurs des ausgewählten Börsenplatzes berechnet. Wählen Sie den Börsenplatz mit der Bilanzwährung aus, damit die Multiples korrekt sind. Die fundamentalen Daten werden von Facunda geliefert; Multiples werden mit dem aktuellen Kurs berechnet. | |||||||
Profil der Mesa Laboratories Aktie
Mesa Laboratories, Inc. engages in the design, manufacture, and market of instruments and disposable products utilized in healthcare, pharmaceutical, food and beverage, medical device, and petrochemical industries. It operates through the following segments: Sterilization and Disinfection Control, Instruments, Continuous Monitoring, and Biopharmaceutical Development. The Sterilization and Disinfection Control segment manufactures and sells biological, cleaning, and chemical indicators. The Instrument segment designs, manufactures, and markets control instruments and disposable products used in the healthcare, pharmaceutical, food and beverage, medical device, industrial hygiene, and environmental air sampling industries. The Biopharmaceutical Development segment develops and sells automated systems for protein analysis and peptide synthesis solutions. The Continuous Monitoring segment includes development of systems used to monitor various environmental parameters. The company was foun